The ROE (Return on Equity) of Takeda Pharmaceutical Co Ltd (4502.T) is 1.56%.
ROE (Return on Equity) shows how effectively a company utilizes shareholders equity to produce earnings. It serves as a key indicator of financial return for investors.
| Date | Value |
|---|---|
| 2025-03-31 | 1.56% |
| 2024-03-31 | 1.98% |
| 2023-03-31 | 4.99% |
| 2022-03-31 | 4.05% |
| 2021-03-31 | 7.27% |
| 2020-03-31 | 0.94% |
| 2019-03-31 | 2.61% |
| 2018-03-31 | 9.36% |
| 2017-03-31 | 6.07% |
| 2016-03-31 | 4.11% |